{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:27:55Z","timestamp":1790893675439,"version":"4.1.0"},"reference-count":174,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3,1]]},"abstract":"<jats:p>The European Stroke Organisation (ESO) guidelines on Moyamoya Angiopathy (MMA), developed according to ESO standard operating procedure and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) methodology, were compiled to assist clinicians in managing patients with MMA in their decision making. A working group involving neurologists, neurosurgeons, a geneticist and methodologists identified nine relevant clinical questions, performed systematic literature reviews and, whenever possible, meta-analyses. Quality assessment of the available evidence was made with specific recommendations. In the absence of sufficient evidence to provide recommendations, Expert Consensus Statements were formulated. Based on low quality evidence from one RCT, we recommend direct bypass surgery in adult patients with haemorrhagic presentation. For ischaemic adult patients and children, we suggest revascularization surgery using direct or combined technique rather than indirect, in the presence of haemodynamic impairment and with an interval of 6\u201312\u2009weeks between the last cerebrovascular event and surgery. In the absence of robust trial, an Expert Consensus was reached recommending long-term antiplatelet therapy in non-haemorrhagic MMA, as it may reduce risk of embolic stroke. We also agreed on the utility of performing pre- and post- operative haemodynamic and posterior cerebral artery assessment. There were insufficient data to recommend systematic variant screening of RNF213 p.R4810K. Additionally, we suggest that long-term MMA neuroimaging follow up may guide therapeutic decision making by assessing the disease progression. We believe that this guideline, which is the first comprehensive European guideline on MMA management using GRADE methods will assist clinicians to choose the most effective management strategy for MMA.<\/jats:p>","DOI":"10.1177\/23969873221144089","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T12:21:49Z","timestamp":1675340509000},"page":"55-84","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":87,"title":["European Stroke Organisation (ESO) Guidelines on Moyamoya angiopathy Endorsed by Vascular European Reference Network (VASCERN)"],"prefix":"10.1093","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2493-628X","authenticated-orcid":false,"given":"Anna","family":"Bersano","sequence":"first","affiliation":[{"name":"Cerebrovascular Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Khan","sequence":"additional","affiliation":[{"name":"Moyamoya Center, University Children\u2019s Hospital Zurich, Switzerland 2"},{"name":"Moyamoya Center for adults, Department of Neurosurgery, University Tubingen, Germany 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0363-862X","authenticated-orcid":false,"given":"Blanca","family":"Fuentes","sequence":"additional","affiliation":[{"name":"Department of Neurology and Stroke Center, Hospital La Paz Institute for Health Research-IdiPAZ (La Paz University Hospital-Universidad Aut\u00f3noma de Madrid), Madrid, Spain 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Acerbi","sequence":"additional","affiliation":[{"name":"Cerebrovascular Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Canavero","sequence":"additional","affiliation":[{"name":"Cerebrovascular Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Tournier-Lasserve","sequence":"additional","affiliation":[{"name":"INSERM U1141, H\u00f4spital Robert Debr\u00e9, Paris, France 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vajcoczy","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Charit\u00e9 Universit\u00e4tsmedizin Berlin, Germany 6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Zedde","sequence":"additional","affiliation":[{"name":"Neurology Unit, Stroke Unit, Azienda Unit\u00e0 Sanitaria Locale \u2013 IRCCS di Reggio Emilia, Italy 7"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"Hussain","sequence":"additional","affiliation":[{"name":"European Stroke Organisation, Basel, Switzerland 8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8611-1630","authenticated-orcid":false,"given":"Sabrina","family":"L\u00e9meret","sequence":"additional","affiliation":[{"name":"European Stroke Organisation, Basel, Switzerland 8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Kraemer","sequence":"additional","affiliation":[{"name":"Department of Neurology, Alfried Krupp Hospital, Essen, Germany 9"},{"name":"Department of Neurology, Medical Faculty, Heinrich Heine University, D\u00fcsseldorf, Germany 10"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Herve","sequence":"additional","affiliation":[{"name":"CNVT-CERVCO et d\u00e9partement de Neurologie, H\u00f4pital Lariboisi\u00e8re, APHP Nord, Paris, France 11"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,3,1]]},"reference":[{"key":"2026012113095910200_bibr1-23969873221144089","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1212\/WNL.18.5.485","article-title":"Spontaneous occlusion of the circle of Willis: a disease apparently confined to Japanese","volume":"18","author":"Kudo","year":"1968","journal-title":"Neurology"},{"key":"2026012113095910200_bibr2-23969873221144089","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/archneur.1969.00480090076012","article-title":"Cerebrovascular moyamoya disease: disease showing abnormal net-like vessels in base of brain","volume":"20","author":"Suzuki","year":"1969","journal-title":"Arch Neurol"},{"key":"2026012113095910200_bibr3-23969873221144089","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10143-018-0994-5","article-title":"Progress in moyamoya disease","volume":"43","author":"Shang","year":"2020","journal-title":"Neurosurg Rev"},{"key":"2026012113095910200_bibr4-23969873221144089","first-page":"91","article-title":"Incidence of moyamoya disease in Denmark: a population-based register study","volume":"129","author":"Birkeland","year":"2018","journal-title":"Acta Neurochir"},{"key":"2026012113095910200_bibr5-23969873221144089","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1212\/01.wnl.0000176066.33797.82","article-title":"Moyamoya disease in Washington State and California","volume":"65","author":"Uchino","year":"2005","journal-title":"Neurology"},{"key":"2026012113095910200_bibr6-23969873221144089","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000345957","article-title":"Epidemiological and clinical features of moyamoya disease in the USA","volume":"40","author":"Kainth","year":"2013","journal-title":"Neuroepidemiology"},{"key":"2026012113095910200_bibr7-23969873221144089","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/STROKEAHA.107.490714","article-title":"Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey","volume":"39","author":"Kuriyama","year":"2008","journal-title":"Stroke"},{"key":"2026012113095910200_bibr8-23969873221144089","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00415-019-09245-9","article-title":"Misdiagnoses and delay of diagnoses in moyamoya angiopathy-a large Caucasian case series","volume":"266","author":"Graf","year":"2019","journal-title":"J Neurol"},{"key":"2026012113095910200_bibr9-23969873221144089","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000442298","article-title":"Research progresses in understanding the pathophysiology of moyamoya disease","volume":"41","author":"Bersano","year":"2016","journal-title":"Cerebrovasc Dis"},{"key":"2026012113095910200_bibr10-23969873221144089","first-page":"49","article-title":"Moyamoya disease and syndromes: from genetics to clinical management","volume":"8","author":"Guey","year":"2015","journal-title":"Appl Clin Genet"},{"key":"2026012113095910200_bibr11-23969873221144089","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1056\/NEJMra0804622","article-title":"Moyamoya disease and moyamoya syndrome","volume":"360","author":"Scott","year":"2009","journal-title":"N Engl J Med"},{"key":"2026012113095910200_bibr12-23969873221144089","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/ene.12702","article-title":"Distinct clinical and radiographic characteristics of moyamoya disease amongst European Caucasians","volume":"22","author":"Acker","year":"2015","journal-title":"Eur J Neurol"},{"key":"2026012113095910200_bibr13-23969873221144089","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.clineuro.2016.11.017","article-title":"Movement symptoms in European Moyamoya angiopathy - first systematic questionnaire study","volume":"152","author":"Kraemer","year":"2017","journal-title":"Clin Neurol Neurosurg"},{"key":"2026012113095910200_bibr14-23969873221144089","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00415-019-09277-1","article-title":"Clinical presentation of moyamoya angiopathy in Europeans: experiences from Germany with 200 patients","volume":"266","author":"Kraemer","year":"2019","journal-title":"J Neurol"},{"key":"2026012113095910200_bibr15-23969873221144089","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1007\/s00415-020-09837-w","article-title":"Moyamoya angiopathy: radiological follow-up findings in Finnish patients","volume":"267","author":"Savolainen","year":"2020","journal-title":"J Neurol"},{"key":"2026012113095910200_bibr16-23969873221144089","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s10072-018-3664-z","article-title":"GEN-O-MA project: an Italian network studying clinical course and pathogenic pathways of moyamoya disease\u2014study protocol and preliminary results","volume":"40","author":"Bersano","year":"2019","journal-title":"Neurol Sci"},{"key":"2026012113095910200_bibr17-23969873221144089","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000343225","article-title":"Clinical features, surgical treatment and long-term outcome in adult patients with moyamoya disease in China","volume":"34","author":"Bao","year":"2012","journal-title":"Cerebrovasc Dis"},{"key":"2026012113095910200_bibr18-23969873221144089","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/jnnp-2011-301387","article-title":"Regional differences in incidence and patient characteristics of moyamoya disease: a systematic review","volume":"83","author":"Kleinloog","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2026012113095910200_bibr19-23969873221144089","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/092986732304160204181543","article-title":"Vasculogenic and angiogenic pathways in moyamoya disease","volume":"23","author":"Bedini","year":"2016","journal-title":"Curr Med Chem"},{"key":"2026012113095910200_bibr20-23969873221144089","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12975-021-00940-2","article-title":"The genetic basis of moyamoya disease","volume":"13","author":"Mertens","year":"2022","journal-title":"Transl Stroke Res"},{"key":"2026012113095910200_bibr21-23969873221144089","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.3390\/ijms23094492","article-title":"Novel multifaceted roles for RNF213 protein","volume":"23","author":"Pollaci","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026012113095910200_bibr22-23969873221144089","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S1474-4422(22)00165-X","article-title":"Moyamoya disease: diagnosis and interventions","volume":"21","author":"Ihara","year":"2022","journal-title":"Lancet Neurol"},{"key":"2026012113095910200_bibr23-23969873221144089","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/STROKEAHA.118.023972","article-title":"Clinical and molecular features of 5 European multigenerational families with moyamoya angiopathy","volume":"50","author":"Grangeon","year":"2019","journal-title":"Stroke"},{"key":"2026012113095910200_bibr24-23969873221144089","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/jmedgenet-2016-104432","article-title":"De novo mutations in CBL causing early-onset paediatric moyamoya angiopathy","volume":"54","author":"Guey","year":"2017","journal-title":"J Med Genet"},{"key":"2026012113095910200_bibr25-23969873221144089","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/ejhg.2017.92","article-title":"Rare RNF213 variants in the C-terminal region encompassing the RING-finger domain are associated with moyamoya angiopathy in Caucasians","volume":"25","author":"Guey","year":"2017","journal-title":"Eur J Hum Genet"},{"key":"2026012113095910200_bibr26-23969873221144089","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12199-017-0680-1","article-title":"Rare variants of RNF213 and moyamoya\/non-moyamoya intracranial artery stenosis\/occlusion disease risk: a meta-analysis and systematic review","volume":"22","author":"Liao","year":"2017","journal-title":"Environ Health Prev Med"},{"key":"2026012113095910200_bibr27-23969873221144089","article-title":"Moyamoya disease in a Six month Caucasian female","volume":"12","author":"Moore","year":"2020","journal-title":"Cureus"},{"key":"2026012113095910200_bibr28-23969873221144089","doi-asserted-by":"crossref","first-page":"e1783","DOI":"10.1212\/WNL.0000000000011653","article-title":"Association of de novo RNF213 variants with childhood onset moyamoya disease and diffuse occlusive vasculopathy","volume":"96","author":"Pinard","year":"2021","journal-title":"Neurology"},{"key":"2026012113095910200_bibr29-23969873221144089","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1002\/ajmg.a.62215","article-title":"A new syndrome of moyamoya disease, kidney dysplasia, aminotransferase elevation, and skin disease associated with de novo variants in RNF213","volume":"185","author":"Strong","year":"2021","journal-title":"Am J Med Genet Part A"},{"key":"2026012113095910200_bibr30-23969873221144089","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/ene.14635","article-title":"Meta-analysis of genotype and phenotype studies to confirm the predictive role of the RNF213 p.R4810K variant for moyamoya disease","volume":"28","author":"Wang","year":"2021","journal-title":"Eur J Neurol"},{"key":"2026012113095910200_bibr31-23969873221144089","doi-asserted-by":"crossref","first-page":"S238","DOI":"10.1016\/S0303-8467(97)00082-6","article-title":"Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (\u2018moyamoya\u2019 disease). Research Committee on Spontaneous Occlusion of the circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan","volume":"99","author":"Fukui","year":"1997","journal-title":"Clin Neurol Neurosurg"},{"key":"2026012113095910200_bibr32-23969873221144089","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2176\/nmc.52.245","article-title":"Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis)","volume":"52","author":"Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis","year":"2012","journal-title":"Neurol Med Chir"},{"key":"2026012113095910200_bibr33-23969873221144089","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1161\/STROKEAHA.118.023426","article-title":"Identifying hypoperfusion in moyamoya disease with arterial spin labeling and an [15 O]-water positron emission tomography\/magnetic resonance imaging normative database","volume":"50","author":"Fan","year":"2019","journal-title":"Stroke"},{"key":"2026012113095910200_bibr34-23969873221144089","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s12149-018-1283-7","article-title":"Accuracy of brain perfusion single-photon emission computed tomography for detecting misery perfusion in adult patients with symptomatic ischemic moyamoya disease","volume":"32","author":"Setta","year":"2018","journal-title":"Ann Nucl Med"},{"key":"2026012113095910200_bibr35-23969873221144089","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1007\/s00415-020-09948-4","article-title":"Correction to: Heritable and non-heritable uncommon causes of stroke","volume":"268","author":"Bersano","year":"2021","journal-title":"J Neurol"},{"key":"2026012113095910200_bibr36-23969873221144089","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000326077","article-title":"Proposal for a new grading of moyamoya disease in adult patients","volume":"32","author":"Czabanka","year":"2011","journal-title":"Cerebrovasc Dis"},{"key":"2026012113095910200_bibr37-23969873221144089","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3389\/fneur.2021.662393","article-title":"Implementation and rationale for a unified clinical and Imaging Protocol for evaluation and treatment of moyamoya angiopathy: a single institutional experience","volume":"12","author":"Larson","year":"2021","journal-title":"Front Neurol"},{"key":"2026012113095910200_bibr38-23969873221144089","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/01.STR.28.6.1170","article-title":"Effects of surgical revascularization on outcome of patients with pediatric moyamoya disease","volume":"28","author":"Ishikawa","year":"1997","journal-title":"Stroke"},{"key":"2026012113095910200_bibr39-23969873221144089","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3171\/2016.11.JNS161688","article-title":"Meta-analysis of the surgical outcomes of symptomatic moyamoya disease in adults","volume":"128","author":"Jeon","year":"2018","journal-title":"J Neurosurg"},{"key":"2026012113095910200_bibr40-23969873221144089","doi-asserted-by":"crossref","first-page":"e2356","DOI":"10.1002\/brb3.2356","article-title":"A meta-analysis of comparisons of various surgical treatments for moyamoya diseases","volume":"11","author":"Lin","year":"2021","journal-title":"Brain Behav"},{"key":"2026012113095910200_bibr41-23969873221144089","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2176\/jns-nmc.2021-0382","article-title":"2021 Japanese guidelines for the management of Moyamoya Disease: Guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society","volume":"62","author":"Fujimura","year":"2022","journal-title":"Neurol Med Chir"},{"key":"2026012113095910200_bibr42-23969873221144089","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.neurol.2017.12.002","article-title":"French clinical practice guidelines for Moyamoya angiopathy","volume":"174","author":"Herv\u00e9","year":"2018","journal-title":"Revue neurologique"},{"key":"2026012113095910200_bibr43-23969873221144089","doi-asserted-by":"crossref","first-page":"e388","DOI":"10.1212\/WNL.0000000000007819","article-title":"Predictors of clinical or cerebral lesion progression in adult moyamoya angiopathy","volume":"93","author":"Herv\u00e9","year":"2019","journal-title":"Neurology"},{"key":"2026012113095910200_bibr44-23969873221144089","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00701-014-2136-3","article-title":"Long-term outcomes in adult patients with ischemic-type moyamoya disease involving posterior circulation","volume":"156","author":"Hishikawa","year":"2014","journal-title":"Acta Neurochir"},{"key":"2026012113095910200_bibr45-23969873221144089","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/neuros\/nyy114","article-title":"Treatment of moyamoya disease","volume":"65","author":"Deng","year":"2018","journal-title":"Neurosurg"},{"key":"2026012113095910200_bibr46-23969873221144089","doi-asserted-by":"crossref","DOI":"10.1177\/23969873211024143","article-title":"European Stroke Organisation (ESO) standard operating procedure for the preparation and publishing of guidelines","volume":"6","author":"Steiner","year":"2021","journal-title":"Eur Stroke J"},{"key":"2026012113095910200_bibr47-23969873221144089","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"2026012113095910200_bibr48-23969873221144089","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1213\/ANE.0000000000002741","article-title":"Significance, errors, power, and sample size: the blocking and tackling of Statistics","volume":"126","author":"Mascha","year":"2018","journal-title":"Anesth Analg"},{"key":"2026012113095910200_bibr49-23969873221144089","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"2026012113095910200_bibr50-23969873221144089","doi-asserted-by":"crossref","DOI":"10.1002\/9781119536604","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2019"},{"key":"2026012113095910200_bibr51-23969873221144089","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2026012113095910200_bibr52-23969873221144089","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"2026012113095910200_bibr53-23969873221144089","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1161\/01.STR.0000221787.70503.ca","article-title":"Clinical features and outcome in North American adults with moyamoya phenomenon","volume":"37","author":"Hallemeier","year":"2006","journal-title":"Stroke"},{"key":"2026012113095910200_bibr54-23969873221144089","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1161\/STROKEAHA.107.513408","article-title":"Moyamoya disease in Europeans","volume":"39","author":"Kraemer","year":"2008","journal-title":"Stroke"},{"key":"2026012113095910200_bibr55-23969873221144089","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/STROKEAHA.116.014538","article-title":"Baseline Hemodynamic Impairment and future stroke risk in adult idiopathic moyamoya phenomenon: results of a prospective Natural History Study","volume":"48","author":"Derdeyn","year":"2017","journal-title":"Stroke"},{"key":"2026012113095910200_bibr56-23969873221144089","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2967\/jnumed.117.195818","article-title":"Brain perfusion imaging under acetazolamide challenge for detection of impaired cerebrovascular reserve capacity: positive findings with 15O-water PET in patients with negative 99mTc-HMPAO SPECT findings","volume":"59","author":"Acker","year":"2018","journal-title":"J Nucl Med"},{"key":"2026012113095910200_bibr57-23969873221144089","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10143-021-01596-0","article-title":"Imaging methods for surgical revascularization in patients with moyamoya disease: an updated review","volume":"45","author":"Du","year":"2022","journal-title":"Neurosurg Rev"},{"key":"2026012113095910200_bibr58-23969873221144089","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.3171\/2009.1.FOCUS08300","article-title":"Quantitative hemodynamic studies in moyamoya disease: a review","volume":"26","author":"Lee","year":"2009","journal-title":"Neurosurg Focus"},{"key":"2026012113095910200_bibr59-23969873221144089","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3174\/ajnr.A5945","article-title":"Standardized MR perfusion scoring system for evaluation of sequential perfusion changes and surgical outcome of moyamoya disease","volume":"40","author":"Lin","year":"2019","journal-title":"Am J Neuroradiol"},{"key":"2026012113095910200_bibr60-23969873221144089","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jns.2015.11.018","article-title":"Long term outcome and predictors of ischemic stroke recurrence in adult moyamoya disease","volume":"359","author":"Noh","year":"2015","journal-title":"J Neurol Sci"},{"key":"2026012113095910200_bibr61-23969873221144089","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3171\/2020.1.JNS192392","article-title":"Impact of cortical hemodynamic failure on both subsequent hemorrhagic stroke and effect of bypass surgery in hemorrhagic moyamoya disease: a supplementary analysis of the Japan Adult Moyamoya Trial","volume":"134","author":"Takahashi","year":"2021","journal-title":"J Neurosurg"},{"key":"2026012113095910200_bibr62-23969873221144089","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7461\/jcen.2014.16.3.241","article-title":"Clinicoepidemiological features of asymptomatic moyamoya disease in adult patients","volume":"16","author":"Yang","year":"2014","journal-title":"J Cerebrovasc Endovasc Neurosurg"},{"key":"2026012113095910200_bibr63-23969873221144089","doi-asserted-by":"crossref","first-page":"106432","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106432","article-title":"\u201cAsymptomatic\u201d Moyamoya angiopathy: is it truly asymptomatic?","volume":"31","author":"Das","year":"2022","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2026012113095910200_bibr64-23969873221144089","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s00701-013-1860-4","article-title":"Ivy sign, misery perfusion, and asymptomatic moyamoya disease: FLAIR imaging and 15O-gas positron emission tomography","volume":"155","author":"Vuignier","year":"2013","journal-title":"Acta Neurochir"},{"key":"2026012113095910200_bibr65-23969873221144089","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1161\/STROKEAHA.116.014529","article-title":"Infarct pattern and collateral status in adult moyamoya disease: a multimodal magnetic resonance imaging study","volume":"48","author":"Kim","year":"2017","journal-title":"Stroke"},{"key":"2026012113095910200_bibr66-23969873221144089","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000356350","article-title":"Clinical course of asymptomatic adult moyamoya disease","volume":"37","author":"Jo","year":"2014","journal-title":"Cerebrovasc Dis"},{"key":"2026012113095910200_bibr67-23969873221144089","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/STROKEAHA.106.478297","article-title":"Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: results of multicenter survey in Japan","volume":"38","author":"Kuroda","year":"2007","journal-title":"Stroke"},{"key":"2026012113095910200_bibr68-23969873221144089","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3340\/jkns.2016.59.2.117","article-title":"Recurrent bleeding in hemorrhagic moyamoya disease : prognostic implications of the perfusion status","volume":"59","author":"Jo","year":"2016","journal-title":"J Korean Neurosurg Soc"},{"key":"2026012113095910200_bibr69-23969873221144089","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s00415-021-10684-6","article-title":"The angiographic presentation of European Moyamoya angiopathy","volume":"269","author":"Pilgram-Pastor","year":"2022","journal-title":"J Neurol"},{"key":"2026012113095910200_bibr70-23969873221144089","first-page":"21351","article-title":"Ischemic and hemorrhagic moyamoya disease in adults: CT findings","volume":"8","author":"Xie","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"2026012113095910200_bibr71-23969873221144089","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1016\/j.wneu.2018.07.179","article-title":"Long-term neurocognitive outcomes in patients with adult moyamoya disease","volume":"119","author":"Nakamizo","year":"2018","journal-title":"World Neurosurg"},{"key":"2026012113095910200_bibr72-23969873221144089","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s10143-019-01192-3","article-title":"Neuropsychological impairment in adults with moyamoya angiopathy: preoperative assessment and correlation to MRI and H215O PET","volume":"43","author":"Roder","year":"2020","journal-title":"Neurosurg Rev"},{"key":"2026012113095910200_bibr73-23969873221144089","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s10143-021-01660-9","article-title":"Quality of life impairment in adult moyamoya patients\u2014preoperative neuropsychological assessment and correlation to MRI and H215O PET findings","volume":"45","author":"Haas","year":"2022","journal-title":"Neurosurg Rev"},{"key":"2026012113095910200_bibr74-23969873221144089","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s00701-016-2941-y","article-title":"Grading of moyamoya disease allows stratification for postoperative ischemia in bilateral revascularization surgery","volume":"158","author":"Czabanka","year":"2016","journal-title":"Acta Neurochir"},{"key":"2026012113095910200_bibr75-23969873221144089","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1007\/s00415-018-9031-4","article-title":"Efficacy of STA-MCA bypass surgery in moyamoya angiopathy: long-term follow-up of the Caucasian Krupp hospital cohort with 81 procedures","volume":"265","author":"Kraemer","year":"2018","journal-title":"J Neurol"},{"key":"2026012113095910200_bibr76-23969873221144089","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3171\/2014.10.JNS132369","article-title":"Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China","volume":"122","author":"Liu","year":"2015","journal-title":"J Neurosurg"},{"key":"2026012113095910200_bibr77-23969873221144089","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1161\/01.STR.0000170709.95185.b1","article-title":"Prediction of the clinical outcome of pediatric moyamoya disease with postoperative basal\/acetazolamide stress brain perfusion SPECT after revascularization surgery","volume":"36","author":"So","year":"2005","journal-title":"Stroke"},{"key":"2026012113095910200_bibr78-23969873221144089","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1034\/j.1600-0404.2002.01359.x","article-title":"Dynamics and embolic activity of symptomatic intra-cranial cerebral artery stenoses","volume":"106","author":"Diehl","year":"2002","journal-title":"Acta Neurol Scand"},{"key":"2026012113095910200_bibr79-23969873221144089","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/jcbfm.1988.53","article-title":"Oxygen extraction fraction at maximally vasodilated tissue in the ischemic brain estimated from the regional CO2 responsiveness measured by positron emission tomography","volume":"8","author":"Kanno","year":"1988","journal-title":"J Cereb Blood Flow Metab"},{"key":"2026012113095910200_bibr80-23969873221144089","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/jnnp.2003.025049","article-title":"Severe haemodynamic stress in selected subtypes of patients with moyamoya disease: a positron emission tomography study","volume":"76","author":"Nariai","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2026012113095910200_bibr81-23969873221144089","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1161\/01.STR.29.7.1281","article-title":"Posthyperventilatory steal response in chronic cerebral hemodynamic stress: a positron emission tomography study","volume":"29","author":"Nariai","year":"1998","journal-title":"Stroke"},{"key":"2026012113095910200_bibr82-23969873221144089","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.3174\/ajnr.A3799","article-title":"Quantitative cerebral perfusion imaging in children and young adults with moyamoya disease: comparison of arterial spin-labeling-MRI and H(2)[(15)O]-PET","volume":"35","author":"Goetti","year":"2014","journal-title":"Am J Neuroradiol"},{"key":"2026012113095910200_bibr83-23969873221144089","doi-asserted-by":"crossref","first-page":"101713","DOI":"10.1016\/j.nicl.2019.101713","article-title":"Hypercapnic BOLD MRI compared to H2(15)O PET\/CT for the hemodynamic evaluation of patients with moyamoya disease","volume":"22","author":"Hauser","year":"2019","journal-title":"NeuroImage Clin"},{"key":"2026012113095910200_bibr84-23969873221144089","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1177\/0271678X221083471","article-title":"Using arterial spin labeling to measure cerebrovascular reactivity in moyamoya disease: insights from simultaneous PET\/MRI","volume":"42","author":"Zhao","year":"2022","journal-title":"J Cereb Blood Flow Metab"},{"key":"2026012113095910200_bibr85-23969873221144089","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00234-021-02814-8","article-title":"Hemodynamic evaluation of patients with moyamoya angiopathy: comparison of resting-state fMRI to breath-hold fMRI and [(15)O]water PET","volume":"64","author":"Zerweck","year":"2022","journal-title":"Neuroradiol"},{"key":"2026012113095910200_bibr86-23969873221144089","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1007\/s10143-020-01459-0","article-title":"Postoperative stroke and neurological outcomes in the early phase after revascularization surgeries for moyamoya disease: an age-stratified comparative analysis","volume":"44","author":"Araki","year":"2021","journal-title":"Neurosurg Rev"},{"key":"2026012113095910200_bibr87-23969873221144089","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3171\/2013.9.PEDS13111","article-title":"Impact of posterior cerebral artery involvement on long-term clinical and social outcome of pediatric moyamoya disease","volume":"12","author":"Funaki","year":"2013","journal-title":"J Neurosurg Pediatr"},{"key":"2026012113095910200_bibr88-23969873221144089","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejpn.2021.10.007","article-title":"Preoperative clinical symptomatology and stroke burden in pediatric moyamoya angiopathy: Defining associated risk variables","volume":"35","author":"Hackenberg","year":"2021","journal-title":"Eur J Paediatr Neurol"},{"key":"2026012113095910200_bibr89-23969873221144089","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3174\/ajnr.A2216","article-title":"Posterior circulation and high prevalence of ischemic stroke among young pediatric patients with moyamoya disease: evidence of angiography-based differences by age at diagnosis","volume":"32","author":"Mugikura","year":"2011","journal-title":"Am J Neuroradiol"},{"key":"2026012113095910200_bibr90-23969873221144089","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4103\/sni.sni_18_18","article-title":"Stenotic changes of the posterior cerebral artery are a major contributing factor for cerebral infarction in moyamoya disease","volume":"9","author":"Morioka","year":"2018","journal-title":"Surg Neurol Int"},{"key":"2026012113095910200_bibr91-23969873221144089","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/dmcn.14708","article-title":"Preoperative neurodevelopment of children with moyamoya angiopathy","volume":"63","author":"Serra","year":"2021","journal-title":"Dev Med Child Neurol"},{"key":"2026012113095910200_bibr92-23969873221144089","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1111\/ene.14477","article-title":"Hemorrhagic patterns and their risk factors in patients with moyamoya disease","volume":"27","author":"Zhang","year":"2020","journal-title":"Eur J Neurol"},{"key":"2026012113095910200_bibr93-23969873221144089","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3171\/2019.12.JNS192938","article-title":"Late (5-20 years) outcomes after STA-MCA anastomosis and encephalo-duro-myo-arterio-pericranial synangiosis in patients with moyamoya disease","volume":"134","author":"Kuroda","year":"2020","journal-title":"J Neurosurg"},{"key":"2026012113095910200_bibr94-23969873221144089","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s13760-017-0844-1","article-title":"Posterior circulation involvement in pediatric and adult patients with moyamoya disease: a single center experience in 574 patients","volume":"118","author":"Zhao","year":"2018","journal-title":"Acta Neurol Belg"},{"key":"2026012113095910200_bibr95-23969873221144089","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3171\/jns.1984.61.6.1032","article-title":"Study of the posterior circulation in moyamoya disease: clinical and neuroradiological evaluation","volume":"61","author":"Miyamoto","year":"1984","journal-title":"J Neurosurg"},{"key":"2026012113095910200_bibr96-23969873221144089","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/STROKEAHA.115.010819","article-title":"Significance of the hemorrhagic site for recurrent bleeding: prespecified analysis in the Japan Adult Moyamoya Trial","volume":"47","author":"Takahashi","year":"2016","journal-title":"Stroke"},{"key":"2026012113095910200_bibr97-23969873221144089","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3171\/2016.11.JNS161650","article-title":"Angiographic features of hemorrhagic moyamoya disease with high recurrence risk: a supplementary analysis of the Japan Adult Moyamoya Trial","volume":"128","author":"Funaki","year":"2018","journal-title":"J Neurosurg"},{"key":"2026012113095910200_bibr98-23969873221144089","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.wneu.2016.03.053","article-title":"Risk factors for newly developed cerebral infarction after surgical revascularization for adults with moyamoya disease","volume":"92","author":"Park","year":"2016","journal-title":"World Neurosurg"},{"key":"2026012113095910200_bibr99-23969873221144089","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1016\/j.wneu.2018.01.212","article-title":"Postoperative cerebral infarction risk factors and postoperative management of pediatric patients with moyamoya disease","volume":"113","author":"Muraoka","year":"2018","journal-title":"World Neurosurg"},{"key":"2026012113095910200_bibr100-23969873221144089","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/jhg.2010.132","article-title":"A genome-wide association study identifies RNF213 as the first moyamoya disease gene","volume":"56","author":"Kamada","year":"2011","journal-title":"J Hum Genet"},{"key":"2026012113095910200_bibr101-23969873221144089","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1212\/WNL.0b013e318249f71f","article-title":"Homozygous c.14576G&gt;A variant of RNF213 predicts early-onset and severe form of moyamoya disease","volume":"78","author":"Miyatake","year":"2012","journal-title":"Neurology"},{"key":"2026012113095910200_bibr102-23969873221144089","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1161\/STROKEAHA.118.024712","article-title":"Prevalence of RNF213 p.R4810K variant in early-onset stroke with intracranial arterial stenosis","volume":"50","author":"Kamimura","year":"2019","journal-title":"Stroke"},{"key":"2026012113095910200_bibr103-23969873221144089","doi-asserted-by":"crossref","first-page":"e017660","DOI":"10.1161\/JAHA.120.017660","article-title":"Role of the RNF213 variant in vascular outcomes in patients with intracranial atherosclerosis","volume":"10","author":"Kim","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2026012113095910200_bibr104-23969873221144089","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3171\/2021.7.PEDS21250","article-title":"Absence of the RNF213 p.R4810K variant may indicate a severe form of pediatric moyamoya disease in Japanese patients","volume":"29","author":"Hara","year":"2022","journal-title":"J Neurosurg Pediatr"},{"key":"2026012113095910200_bibr105-23969873221144089","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000499699","article-title":"Genotype-phenotype correlation in long-term cohort of Japanese patients with moyamoya disease","volume":"47","author":"Nomura","year":"2019","journal-title":"Cerebrovasc Dis"},{"key":"2026012113095910200_bibr106-23969873221144089","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1002\/ajmg.a.37230","article-title":"Atypical presentation of moyamoya disease in an infant with a de novoRNF213variant","volume":"167","author":"Harel","year":"2015","journal-title":"Am J Med Genet A"},{"key":"2026012113095910200_bibr107-23969873221144089","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1468-1331.2011.03481.x","article-title":"What is the expert\u2019s option on antiplatelet therapy in moyamoya disease? Results of a worldwide survey","volume":"19","author":"Kraemer","year":"2012","journal-title":"Eur J Neurol"},{"key":"2026012113095910200_bibr108-23969873221144089","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.08.030","article-title":"Trends of antiplatelet therapy for the management of moyamoya disease in Japan: results of a nationwide survey","volume":"27","author":"Oki","year":"2018","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2026012113095910200_bibr109-23969873221144089","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1007\/s00381-021-05074-2","article-title":"Current trends in pediatric moyamoya: a survey of international practitioners","volume":"37","author":"Srinivasan","year":"2021","journal-title":"Childs Nerv Syst"},{"key":"2026012113095910200_bibr110-23969873221144089","doi-asserted-by":"crossref","first-page":"19367","DOI":"10.1038\/s41598-021-99009-1","article-title":"Benefits and risks of antiplatelet medication in hemodynamically stable adult moyamoya disease","volume":"11","author":"Pang","year":"2021","journal-title":"Sci Rep"},{"key":"2026012113095910200_bibr111-23969873221144089","doi-asserted-by":"crossref","first-page":"608000","DOI":"10.3389\/fneur.2020.608000","article-title":"Efficacy and safety of antiplatelet agents for adult patients with ischemic moyamoya disease","volume":"11","author":"Ye","year":"2020","journal-title":"Front Neurol"},{"key":"2026012113095910200_bibr112-23969873221144089","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.10.003","article-title":"Effects of surgery and antiplatelet therapy in ten-year follow-up from the registry study of research committee on moyamoya disease in Japan","volume":"25","author":"Yamada","year":"2016","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2026012113095910200_bibr113-23969873221144089","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1177\/0883073817718730","article-title":"Moyamoya disease in children: results from the International Pediatric Stroke Study","volume":"32","author":"Lee","year":"2017","journal-title":"J Child Neurol"},{"key":"2026012113095910200_bibr114-23969873221144089","doi-asserted-by":"crossref","first-page":"e009942","DOI":"10.1136\/bmjopen-2015-009942","article-title":"Prehospital antiplatelet use and functional status on admission of patients with non-haemorrhagic moyamoya disease: a nationwide retrospective cohort study (J-ASPECT study)","volume":"6","author":"Onozuka","year":"2016","journal-title":"BMJ Open"},{"key":"2026012113095910200_bibr115-23969873221144089","doi-asserted-by":"crossref","first-page":"e017701","DOI":"10.1161\/JAHA.120.017701","article-title":"Association of antiplatelet therapy, including cilostazol, with improved survival in patients with moyamoya disease in a nationwide study","volume":"10","author":"Seo","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2026012113095910200_bibr116-23969873221144089","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/ene.12392","article-title":"Microembolic signals predict cerebral ischaemic events in patients with moyamoya disease","volume":"21","author":"Chen","year":"2014","journal-title":"Eur J Neurol"},{"key":"2026012113095910200_bibr117-23969873221144089","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000083246","article-title":"Hemodynamic reserve and high-intensity transient signals in moyamoya disease","volume":"19","author":"Horn","year":"2005","journal-title":"Cerebrovasc Dis"},{"key":"2026012113095910200_bibr118-23969873221144089","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1161\/STROKEAHA.118.022490","article-title":"Clinical role of microembolic signals in adult moyamoya disease with ischemic stroke","volume":"50","author":"Jeon","year":"2019","journal-title":"Stroke"},{"key":"2026012113095910200_bibr119-23969873221144089","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/23969873211060819","article-title":"Micro-embolic signal monitoring in stroke subtypes: A systematic review and meta-analysis of 58 studies","volume":"6","author":"Sudheer","year":"2021","journal-title":"Eur Stroke J"},{"key":"2026012113095910200_bibr120-23969873221144089","doi-asserted-by":"crossref","first-page":"6605","DOI":"10.1007\/s00415-022-11323-4","article-title":"Microembolic signals and antiplatelet therapy in Moyamoya angiopathy","volume":"269","author":"Pompsch","year":"2022","journal-title":"J Neurol"},{"key":"2026012113095910200_bibr121-23969873221144089","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3389\/fneur.2017.00425","article-title":"Direct visualization of arterial emboli in moyamoya syndrome","volume":"8","author":"Shulman","year":"2017","journal-title":"Front Neurol"},{"key":"2026012113095910200_bibr122-23969873221144089","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1161\/STROKEAHA.113.004386","article-title":"Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial","volume":"45","author":"Miyamoto","year":"2014","journal-title":"Stroke"},{"key":"2026012113095910200_bibr123-23969873221144089","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3171\/2016.8.JNS152875","article-title":"Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults","volume":"127","author":"Jang","year":"2017","journal-title":"J Neurosurg"},{"key":"2026012113095910200_bibr124-23969873221144089","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.3171\/2015.6.JNS151105","article-title":"Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia","volume":"124","author":"Kim","year":"2016","journal-title":"J Neurosurg"},{"key":"2026012113095910200_bibr125-23969873221144089","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00701-012-1325-1","article-title":"Long-term follow-up results in 142 adult patients with moyamoya disease according to management modality","volume":"154","author":"Lee","year":"2012","journal-title":"Acta Neurochir"},{"key":"2026012113095910200_bibr126-23969873221144089","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2176\/nmc.ra.2014-0305","article-title":"Asymptomatic moyamoya disease: literature review and ongoing AMORE study","volume":"55","author":"Kuroda","year":"2015","journal-title":"Neurol Med Chir"},{"key":"2026012113095910200_bibr127-23969873221144089","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3171\/2017.9.JNS17576","article-title":"High rebleeding risk associated with choroidal collateral vessels in hemorrhagic moyamoya disease: analysis of a nonsurgical cohort in the Japan Adult Moyamoya Trial","volume":"130","author":"Funaki","year":"2019","journal-title":"J Neurosurg"},{"key":"2026012113095910200_bibr128-23969873221144089","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000518725","article-title":"Five-year outcomes of medical management alone for adult patients with ischemic moyamoya disease without cerebral misery perfusion","volume":"51","author":"Kitakami","year":"2022","journal-title":"Cerebrovasc Dis"},{"key":"2026012113095910200_bibr129-23969873221144089","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/neuros\/nyy234","article-title":"Two-Year clinical, cerebral hemodynamic, and cognitive outcomes of adult patients undergoing medication alone for symptomatically ischemic moyamoya disease without cerebral misery perfusion: a prospective cohort study","volume":"84","author":"Miyoshi","year":"2019","journal-title":"Neurosurg"},{"key":"2026012113095910200_bibr130-23969873221144089","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000330351","article-title":"Characterization of direct and indirect cerebral revascularization for the treatment of European patients with moyamoya disease","volume":"32","author":"Czabanka","year":"2011","journal-title":"Cerebrovasc Dis"},{"key":"2026012113095910200_bibr131-23969873221144089","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/neuros\/nyx140","article-title":"Berlin grading system can stratify the onset and predict perioperative complications in adult moyamoya disease","volume":"81","author":"Kashiwazaki","year":"2017","journal-title":"Neurosurg"},{"key":"2026012113095910200_bibr132-23969873221144089","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fneur.2019.00014","article-title":"Clinical features, surgical reatment, and long-erm outcome of a multicenter cohort of Pediatric Moyamoya","volume":"10","author":"Zheng","year":"2019","journal-title":"Front Neurol"},{"key":"2026012113095910200_bibr133-23969873221144089","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0303-8467(97)00033-4","article-title":"Natural history of moyamoya disease: comparison of activity of daily living in surgery and non surgery groups","volume":"99","author":"Choi","year":"1997","journal-title":"Clin Neurol Neurosurg"},{"key":"2026012113095910200_bibr134-23969873221144089","doi-asserted-by":"crossref","first-page":"892445","DOI":"10.3389\/fped.2022.892445","article-title":"Pediatric Moyamoya Disease and syndrome in Italy: A Multicenter Cohort","volume":"10","author":"Po","year":"2022","journal-title":"Front Pediatr"},{"key":"2026012113095910200_bibr135-23969873221144089","doi-asserted-by":"crossref","first-page":"e763","DOI":"10.1212\/WNL.0000000000005026","article-title":"Clinical features, course, and outcomes of a UK cohort of pediatric moyamoya","volume":"90","author":"Tho-Calvi","year":"2018","journal-title":"Neurology"},{"key":"2026012113095910200_bibr136-23969873221144089","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1227\/01.NEU.0000114140.41509.14","article-title":"Moyamoya disease among young patients: its aggressive clinical course and the role of active surgical treatment","volume":"54","author":"Kim","year":"2004","journal-title":"Neurosurg"},{"key":"2026012113095910200_bibr137-23969873221144089","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1161\/STROKEAHA.119.025609","article-title":"Long-term outcomes of indirect bypass for 629 children with moyamoya disease: Longitudinal and cross-sectional analysis","volume":"50","author":"Ha","year":"2019","journal-title":"Stroke"},{"key":"2026012113095910200_bibr138-23969873221144089","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3171\/2019.1.PEDS18457","article-title":"Results of more than 20 years of follow-up in pediatric patients with moyamoya disease undergoing pial synangiosis","volume":"23","author":"Riordan","year":"2019","journal-title":"J Neurosurg Pediatr"},{"key":"2026012113095910200_bibr139-23969873221144089","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1227\/NEU.0b013e3182333c47","article-title":"Quantitative angiographic comparison with the OSIRIS program between the direct and indirect revascularization modalities in adult moyamoya disease","volume":"70","author":"Bang","year":"2012","journal-title":"Neurosurg"},{"key":"2026012113095910200_bibr140-23969873221144089","doi-asserted-by":"crossref","first-page":"191","DOI":"10.7461\/jcen.2013.15.3.191","article-title":"Thirteen-year experience of 44 patients with adult hemorrhagic moyamoya disease from a single institution: clinical analysis by management modality","volume":"15","author":"Choi","year":"2013","journal-title":"J Cerebrovasc Endovasc Neurosurg"},{"key":"2026012113095910200_bibr141-23969873221144089","article-title":"Follow-up outcomes of different bypass surgical modalities for adults with ischaemic-type moyamoya disease","author":"Gao","journal-title":"Br J Neurosurg"},{"key":"2026012113095910200_bibr142-23969873221144089","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00701-012-1545-4","article-title":"Adult moyamoya after revascularization","volume":"155","author":"Gross","year":"2013","journal-title":"Acta Neurochir"},{"key":"2026012113095910200_bibr143-23969873221144089","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2176\/nmc.52.333","article-title":"Surgical treatment of moyamoya disease in adults: combined direct and indirect vs. indirect bypass surgery","volume":"52","author":"Kim","year":"2012","journal-title":"Neurol Med Chir"},{"key":"2026012113095910200_bibr144-23969873221144089","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/neuros\/nyab156","article-title":"Direct vs indirect revascularization in a North American cohort of moyamoya disease","volume":"89","author":"Lai","year":"2021","journal-title":"Neurosurg"},{"key":"2026012113095910200_bibr145-23969873221144089","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/STROKEAHA.117.018563","article-title":"Surgical management of moyamoya disease","volume":"49","author":"Acker","year":"2018","journal-title":"Stroke"},{"key":"2026012113095910200_bibr146-23969873221144089","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.3171\/2017.2.JNS162405","article-title":"Direct versus indirect bypasses for adult ischemic-type moyamoya disease: a propensity score-matched analysis","volume":"128","author":"Deng","year":"2018","journal-title":"J Neurosurg"},{"key":"2026012113095910200_bibr147-23969873221144089","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.wneu.2016.04.083","article-title":"Perioperative complications and long-term outcomes after bypasses in adults with moyamoya disease: a systematic review and meta-analysis","volume":"92","author":"Sun","year":"2016","journal-title":"World Neurosurg"},{"key":"2026012113095910200_bibr148-23969873221144089","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.4103\/0028-3886.178046","article-title":"Moyamoya disease: experience with direct and indirect revascularization in 70 patients from a nonendemic region","volume":"64","author":"Sadashiva","year":"2016","journal-title":"Neurol India"},{"key":"2026012113095910200_bibr149-23969873221144089","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s007010050035","article-title":"Neovascularization (angiogenesis) after revascularization in moyamoya disease. Which technique is most useful for moyamoya disease?","volume":"142","author":"Houkin","year":"2000","journal-title":"Acta Neurochir"},{"key":"2026012113095910200_bibr150-23969873221144089","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10143-019-01086-4","article-title":"Predictive factors for acute thrombogenesis occurring immediately after bypass procedure for moyamoya disease","volume":"43","author":"Mikami","year":"2020","journal-title":"Neurosurg Rev"},{"key":"2026012113095910200_bibr151-23969873221144089","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1016\/j.wneu.2021.08.098","article-title":"Imaging Pattern and the mechanisms of postoperative infarction after indirect revascularization in patients with moyamoya disease","volume":"155","author":"Hara","year":"2021","journal-title":"World Neurosurg"},{"key":"2026012113095910200_bibr152-23969873221144089","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.wneu.2013.06.010","article-title":"Risk profile in extracranial\/intracranial bypass surgery\u2013the role of antiplatelet agents, disease pathology, and surgical technique in 168 direct revascularization procedures","volume":"82","author":"Schubert","year":"2014","journal-title":"World Neurosurg"},{"key":"2026012113095910200_bibr153-23969873221144089","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00701-020-04668-0","article-title":"Effects of aspirin and heparin treatment on perioperative outcomes in patients with moyamoya disease","volume":"163","author":"Kanamori","year":"2021","journal-title":"Acta Neurochir"},{"key":"2026012113095910200_bibr154-23969873221144089","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.wneu.2017.06.057","article-title":"Effect of aspirin in postoperative management of adult ischemic moyamoya disease","volume":"105","author":"Zhao","year":"2017","journal-title":"World Neurosurg"},{"key":"2026012113095910200_bibr155-23969873221144089","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/svn-2020-000770","article-title":"Effects and safety of aspirin use in patients after cerebrovascular bypass procedures","volume":"6","author":"Lu","year":"2021","journal-title":"Stroke Vasc Neurol"},{"key":"2026012113095910200_bibr156-23969873221144089","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1007\/s00415-018-8997-2","article-title":"Moyamoya angiopathy: early postoperative course within 3 months after STA-MCA-bypass surgery in Europe-a retrospective analysis of 64 procedures","volume":"265","author":"Kraemer","year":"2018","journal-title":"J Neurol"},{"key":"2026012113095910200_bibr157-23969873221144089","doi-asserted-by":"crossref","first-page":"e750","DOI":"10.1016\/j.wneu.2018.07.258","article-title":"Predicting the occurrence of hemorrhagic cerebral hyperperfusion syndrome using regional cerebral blood flow after direct bypass surgery in patients with moyamoya disease","volume":"119","author":"Ishikawa","year":"2018","journal-title":"World Neurosurg"},{"key":"2026012113095910200_bibr158-23969873221144089","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/bja\/aes470","article-title":"Predictive factors of symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in adult patients with moyamoya disease","volume":"110","author":"Hwang","year":"2013","journal-title":"Br J Anaesth"},{"key":"2026012113095910200_bibr159-23969873221144089","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.wneu.2019.11.065","article-title":"Cerebral hyperperfusion syndrome after revascularization surgery in patients with moyamoya disease: systematic review and meta-analysis","volume":"135","author":"Yu","year":"2020","journal-title":"World Neurosurg"},{"key":"2026012113095910200_bibr160-23969873221144089","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1159\/000509740","article-title":"Prediction of cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis by three-dimensional-time-of-flight magnetic resonance angiography in adult patients with moyamoya disease","volume":"49","author":"Nishizawa","year":"2020","journal-title":"Cerebrovasc Dis"},{"key":"2026012113095910200_bibr161-23969873221144089","doi-asserted-by":"crossref","first-page":"104846","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104846","article-title":"Postoperative functional outcomes and prognostic factors in two types of adult moyamoya diseases","volume":"29","author":"Zhang","year":"2020","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2026012113095910200_bibr162-23969873221144089","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.3171\/2020.4.JNS20643","article-title":"Development and external validation of a clinical prediction model for functional impairment after intracranial tumor surgery","volume":"134","author":"Staartjes","year":"2021","journal-title":"J Neurosurg"},{"key":"2026012113095910200_bibr163-23969873221144089","doi-asserted-by":"crossref","first-page":"e412","DOI":"10.1016\/j.wneu.2018.02.193","article-title":"The optimum operative time of revascularization for patients with moyamoya disease following acute onset","volume":"114","author":"Xu","year":"2018","journal-title":"World Neurosurg"},{"key":"2026012113095910200_bibr164-23969873221144089","first-page":"433","article-title":"Risk factors for postoperative ischemic complications in patients with moyamoya disease","volume":"103","author":"Kim","year":"2005","journal-title":"J Neurosurg"},{"key":"2026012113095910200_bibr165-23969873221144089","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000093238","article-title":"Progression of unilateral moyamoya disease: a clinical series","volume":"22","author":"Kelly","year":"2006","journal-title":"Cerebrovasc Dis"},{"key":"2026012113095910200_bibr166-23969873221144089","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2176\/nmc.52.311","article-title":"Clinical features of adult moyamoya disease with special reference to the diagnosis","volume":"52","author":"Kim","year":"2012","journal-title":"Neurol Med Chir"},{"key":"2026012113095910200_bibr167-23969873221144089","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s00381-011-1469-y","article-title":"Natural history and progression factors of unilateral moyamoya disease in pediatric patients","volume":"27","author":"Park","year":"2011","journal-title":"Childs Nerv Syst"},{"key":"2026012113095910200_bibr168-23969873221144089","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s10143-021-01677-0","article-title":"Angiographic disease progression in medically treated adult patients with ischemic moyamoya disease without cerebral misery perfusion: supplementary analysis of a 5-year prospective cohort","volume":"45","author":"Oomori","year":"2022","journal-title":"Neurosurg Rev"},{"key":"2026012113095910200_bibr169-23969873221144089","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00701-013-1975-7","article-title":"Incidence of late cerebrovascular events after direct bypass among children with moyamoya disease: a descriptive longitudinal study at a single center","volume":"156","author":"Funaki","year":"2014","journal-title":"Acta Neurochir"},{"key":"2026012113095910200_bibr170-23969873221144089","doi-asserted-by":"crossref","first-page":"E17","DOI":"10.3171\/FOC\/2008\/24\/2\/E17","article-title":"Progression of disease in unilateral moyamoya syndrome","volume":"24","author":"Smith","year":"2008","journal-title":"Neurosurg Focus"},{"key":"2026012113095910200_bibr171-23969873221144089","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1161\/01.STR.0000182256.32489.99","article-title":"Incidence and clinical features of disease progression in adult moyamoya disease","volume":"36","author":"Kuroda","year":"2005","journal-title":"Stroke"},{"key":"2026012113095910200_bibr172-23969873221144089","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.3171\/2020.9.JNS202709","article-title":"Blood volume flow in the superficial temporal artery assessed by duplex sonography: predicting extracranial-intracranial bypass patency in moyamoya disease","volume":"135","author":"Connolly","year":"2021","journal-title":"J Neurosurg"},{"key":"2026012113095910200_bibr173-23969873221144089","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00701-016-3073-0","article-title":"Early and noninvasive evaluation using superficial temporal artery duplex ultrasonography after indirect bypass for adult ischemic moyamoya disease","volume":"159","author":"Ogawa","year":"2017","journal-title":"Acta Neurochir"},{"key":"2026012113095910200_bibr174-23969873221144089","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/ijs.12583","article-title":"The European Stroke Organisation Guidelines: a standard operating procedure","volume":"10","author":"Ntaios","year":"2015","journal-title":"Int J Stroke"}],"container-title":["European Stroke Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/23969873221144089","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/23969873221144089","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/esj\/article-pdf\/8\/1\/55\/64654480\/23969873221144089.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/esj\/article-pdf\/8\/1\/55\/64654480\/23969873221144089.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:11:07Z","timestamp":1769019067000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/esj\/article\/8\/1\/55\/8269027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":174,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3,1]]}},"URL":"https:\/\/doi.org\/10.1177\/23969873221144089","relation":{},"ISSN":["2396-9873","2396-9881"],"issn-type":[{"value":"2396-9873","type":"print"},{"value":"2396-9881","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,3,1]]},"published":{"date-parts":[[2023,3,1]]}}}